Showing results (61-70 of 25,160) with videos related to
Sort By:
Pageof 2,516
Oncotarget|July 23, 2016
MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatmentPier Paolo Leoncini, Alice Bertaina, Dimitrios Papaioannou, et al.Oncotarget|July 23, 2016
Decreased radiation doses to tongue with "stick-out" tongue position over neutral tongue position in head and neck cancer patients who refused or could not tolerate an intraoral device (bite-block, tongue blade, or mouthpiece) due to trismus, gag reflex, or discomfort during intensity-modulated radiation therapyWhoon Jong Kil, Christina Kulasekere, Ronald Derrwaldt, et al.Oncotarget|July 25, 2016
miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathwaysXiaoyan Sun, Jun Li, Yanhong Sun, et al.Oncotarget|July 25, 2016
Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinomaAnna Maria Rachiglio, Riziero Esposito Abate, Alessandra Sacco, et al.Oncotarget|July 25, 2016
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demandManal Amoury, Dirk Bauerschlag, Felix Zeppernick, et al.Oncotarget|July 25, 2016
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4Chengyuan Xue, Denise M T Yu, Samuele Gherardi, et al.Oncotarget|July 21, 2016
Leukocyte telomere length and mortality risk in patients with type 2 diabetesAnna Rita Bonfigli, Liana Spazzafumo, Francesco Prattichizzo, et al.Oncotarget|July 21, 2016
YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acidGuanglin Xu, Jing Wang, Fangfang Wu, et al.Oncotarget|July 21, 2016
Prognostic impact of MYH9 expression on patients with acute myeloid leukemiaMengxia Yu, Jinghan Wang, Zhijuan Zhu, et al.Oncotarget|July 21, 2016
Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activationMarina Saisana, S Michael Griffin, Felicity E B MayPageof 2,516